Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001387131-19-003428

Options or other derivatives

  • Chief Executive Officer acquired 259,515 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LEDERMAN SETH · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-05-06 Grant or award : show line 1 in the form Stock Option +129,758 129,758 D
2019-05-06 Grant or award : show line 2 in the form Stock Option +129,757 129,757 D
Loading xslF345X03/ownership.xml…